Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

Intact Vascular, TOBA III clinical study, Europe, Tack Endovascular System, peripheral artery disease, PAD
News | Peripheral Artery Disease (PAD) | June 07, 2016
June 7, 2016 — Intact Vascular Inc. announced that its Tack Optimized Balloon Angioplasty III (TOBA III) clinical trial...
News | Stents Bioresorbable | June 06, 2016
June 6, 2016 — Amaranth Medical announced that it completed enrollment in May in the RENASCENT-II study of its novel...
Biotronik, ORIENT trial results, EuroPCR 2016, Orsiro DES, hybrid drug-eluting stent
News | Stents Drug Eluting | June 03, 2016
June 3, 2016 — Biotronik announced results establishing non-inferiority of the Orsiro hybrid drug-eluting stent (DES)...
congenital heart, pulmonary artery stenting, JACC study
News | Congenital Heart | May 31, 2016
May 31, 2016 — In a recent study, the use of a stent to repair pulmonary artery stenosis in children and adults with...
Biotronik, Magmaris bioresorbable magnesium scaffold, BIOSOLVE-II Trial, 12-month results, EuroPCR 2016
News | Stents Bioresorbable | May 17, 2016
May 17, 2016 — Biotronik presented 12-month data from the BIOSOLVE-II trial during a Hotline Session at EuroPCR 2016....

Biosensors' Biomatrix stent.

Feature | Stents | May 16, 2016
May 16, 2016 — Cardinal Health announced it has entered into a distribution agreement with Biosensors that enables...
TOBA-BTK study, twelve-month results, SCAI 2016, Tack Endovascular System, critical limb ischemia
News | Peripheral Artery Disease (PAD) | May 05, 2016
May 5, 2016 — Intact Vascular Inc. announced that positive twelve-month results from its Tack Optimized Balloon...
Technology | Stents Peripheral | April 27, 2016
April 27, 2016 — Veniti Inc. announced the first successful treatment with the Vici Verto Venous Stent System of a...
Medtronic, Drug-Filled Stent, RevElution Trial results, ACC.16, CE Mark
News | Stents Drug Eluting | April 21, 2016
April 21, 2016 — Medtronic plc announced new clinical data from one of the endpoints in the RevElution Trial for its...
STEMI, delayed or deferred stent implantation, DANAMI-3-DEFER trial, ACC.16
News | Cath Lab | April 18, 2016
April 18, 2016 — Delayed or deferred stent implantation in patients showed no clinical benefit in patients experiencing...
Absorb, bioresorbable stents
Feature | Stents Bioresorbable | April 13, 2016 | Dave Fornell
Bioresorbable stents have been one of the hottest new cardiovascular technologies discussed at cardiology meetings over...
Videos | Stents Bioresorbable | April 12, 2016
Gregg Stone, M.D., director of cardiovascular research and education at Columbia University Medical Center / New York-...
Medinol, NIRTRAKS Study, NIRxcell Stent System, first patient

Image courtesy of Medinol

News | Stents | March 24, 2016
March 24, 2016 — Medinol announced the enrollment of their first patient in the U.S. NIRTRAKS Study. NIRTRAKS is a post...
PinnacleHealth Cardiovascular Institute, TOBA II study, first patient, Tack Endovascular System, PAD
News | Peripheral Artery Disease (PAD) | March 22, 2016
March 22, 2016 — PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania into the TOBA II...
Boston Scientific, Eluvia vascular stent system, CE Mark, peripheral artery disease
News | Stents Peripheral | March 17, 2016
March 17, 2016 — Boston Scientific announced in late February that the Eluvia Drug-Eluting Vascular Stent System...